Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. (Q30331327)

18 June 2017

1 reference

title

Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. (English)

1 reference

18 June 2017

0 references

1 reference

Michael M Thomson

1

1 reference

PubMed ID

12150845

18 June 2017

Lucía Pérez-Alvarez

series ordinal

2

1 reference

PubMed ID

12150845

18 June 2017

Rafael Nájera

series ordinal

3

1 reference

18 June 2017

1 August 2002

1 reference

Lancet Infectious Diseases

18 June 2017

1 reference

18 June 2017

2

1 reference

18 June 2017

8

1 reference

18 June 2017

461-471

1 reference

Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates

18 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Timing the ancestor of the HIV-1 pandemic strains

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Identification of a Newly Characterized HIV-1 BG Intersubtype Circulating Recombinant Form in Galicia, Spain, Which Exhibits a Pseudotype-Like Virion Structure

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Molecular epidemiology of HIV type 1 infection in Portugal: high prevalence of non-B subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

High HIV-1 genetic diversity in Cuba

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Estimated Global Distribution and Regional Spread of HIV-1 Genetic Subtypes in the Year 2000

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Widespread circulation of a B/F intersubtype recombinant form among HIV-1-infected individuals in Buenos Aires, Argentina

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into Western countries.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Molecular epidemiology of viral infections. How sequence information helps us understand the evolution and dissemination of viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

HIV-1 drug resistance in newly infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Acute HIV infection: impact on the spread of HIV and transmission of drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide. HIV Variant Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Resistance-associated mutations in the human immunodeficiency virus type 1 subtype c protease gene from treated and untreated patients in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Genotypic variation of HIV-1 reverse transcriptase and protease: comparative analysis of clade C and clade B

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

HIV-1 subtype G and BG recombinant viruses in Spanish natives: evidence of characteristic mutations in reverse transcriptase and protease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Differences in chemokine coreceptor usage between genetic subtypes of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Determinants for the syncytium-inducing phenotype of HIV-1 subtype F isolates are located in the V3 region

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

HIV type 1 envelope subtype C sequences from recent seroconverters in Zimbabwe.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Biological characteristics of newly described HIV-1 BG recombinants in Spanish individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

HIV-1 LTR subtype and perinatal transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Human immunodeficiency virus type 1 subtypes differ in disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Clinical disease associated with HIV-1 subtype B‚ _and E infection among 2104 patients in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

African HIV-1 subtype C and rate of progression among Ethiopian immigrants in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Evaluation of United States-licensed human immunodeficiency virus immunoassays for detection of group M viral variants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion among individuals with HIV-1 subtype B or E infection in Thailand.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA ver

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Prospects for vaccine protection against HIV-1 infection and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Characterization of sera from subjects infected with HIV-1 subtypes B and E in Thailand by antibody binding and neutralization.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Fusion-competent vaccines: broad neutralization of primary isolates of HIV

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Augmented serum neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates in two groups of HIV-1-infected long-term nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: relevance to HIV-1 vaccine trials in Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Cytotoxic T-cell recognition of HIV-1 cross-clade and clade-specific epitopes in HIV-1-infected Thai and Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Failure of a human immunodeficiency virus type 1 (HIV-1) subtype B-derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

FIV infection of the domestic cat: an animal model for AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Approaches to the development of broadly protective HIV vaccines: challenges posed by the genetic, biological and antigenic variability of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

The HIV vaccine pipeline, from preclinical to phase III.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900343-2

7 January 2021

10.1016/S1473-3099(02)00343-2

Identifiers

DOI

1 reference

18 June 2017

1 reference

PubMed ID

12150845